Managing myeloproliferative neoplasms evidence based on the ELN treatment recommendations 2018
Leukemia
.
2018 May;32(5):1055-1056.
doi: 10.1038/s41375-018-0079-z.
Epub 2018 Feb 27.
Authors
Florian H Heidel
1
,
Robert Peter Gale
2
,
Andreas Hochhaus
3
Affiliations
1
Klinik für Innere Medizin II, Hämatologie und Onkologie, Universitätsklinikum Jena, Jena, Germany.
2
Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK.
3
Klinik für Innere Medizin II, Hämatologie und Onkologie, Universitätsklinikum Jena, Jena, Germany. andreas.hochhaus@med.uni-jena.de.
PMID:
29515237
DOI:
10.1038/s41375-018-0079-z
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Myeloproliferative Disorders / therapy*
Neoplasms / therapy*
Practice Guidelines as Topic